HYPAZ: Hypertension Induced by Pazopanib
Status: TERMINATED
Study type: INTERVENTIONAL
Conditions: Renal Cell Carcinoma|Soft Tissue Sarcoma|Glioblastoma|Ovarian Cancer|Cervical Cancer|Breast Cancer|Non-small Cell Lung Cancer|Small Cell Lung Cancer|Pancreatic Cancer|Melanoma|Gastrointestinal Cancer
Interventions: DRUG: Pazopanib
Sponsor: Cambridge University Hospitals NHS Foundation Trust
Collaborators: University of Cambridge